Armata Pharmaceuticals (ARMP) Net Cash Flow Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 89.97% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -13.44% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 33.37% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -29.82% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 32.17% |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | -36.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.08% |
| Dec 31, 2025 | 16.78% |
| Sep 30, 2025 | 42.59% |
| Jun 30, 2025 | 7.93% |
| Mar 31, 2025 | -61.64% |
| Dec 31, 2024 | -63.74% |
| Sep 30, 2024 | -19.27% |
| Jun 30, 2024 | -32.55% |
| Mar 31, 2024 | 23.46% |
| Dec 31, 2023 | -19.11% |
| Sep 30, 2023 | 70.71% |
| Jun 30, 2023 | -49.01% |
| Mar 31, 2023 | -17.87% |
| Dec 31, 2022 | -58.25% |
| Sep 30, 2022 | -37.08% |
| Jun 30, 2022 | -49.50% |
| Mar 31, 2022 | 137.24% |
| Dec 31, 2021 | -40.24% |
| Sep 30, 2021 | -38.06% |
| Jun 30, 2021 | -33.23% |
| Mar 31, 2021 | 60.91% |
| Dec 31, 2020 | -33.98% |
| Sep 30, 2020 | -46.65% |
| Jun 30, 2020 | -36.90% |
| Mar 31, 2020 | 92.66% |
| Dec 31, 2019 | -52.17% |
| Sep 30, 2019 | -12.32% |
| Jun 30, 2019 | 62.99% |
| Mar 31, 2019 | -4.05% |
| Dec 31, 2018 | 44.17% |
| Sep 30, 2018 | 7.41% |
| Jun 30, 2018 | 2.93% |
| Mar 31, 2018 | -32.61% |
| Dec 31, 2017 | 6.82% |
| Sep 30, 2017 | 23.51% |
| Jun 30, 2017 | 55.22% |
| Mar 31, 2017 | 3.62% |
| Dec 31, 2016 | -51.72% |
| Sep 30, 2016 | -7.94% |
| Jun 30, 2016 | -34.86% |